| Baricitinib: from rheumatoid arthritis to COVID‐19 S Assadiasl, Y Fatahi, B Mosharmovahed, B Mohebbi, MH Nicknam The Journal of Clinical Pharmacology 61 (10), 1274-1285, 2021 | 55 | 2021 |
| COVID-19: Significance of antibodies S Assadiasl, Y Fatahi, M Zavvar, MH Nicknam Human antibodies 28 (4), 287-297, 2020 | 43 | 2020 |
| Ankylosing spondylitis and mesenchymal stromal/stem cell therapy: a new therapeutic approach K Abdolmohammadi, FD Pakdel, H Aghaei, S Assadiasl, Y Fatahi, ... Biomedicine & Pharmacotherapy 109, 1196-1205, 2019 | 39 | 2019 |
| Altered suppressor function of regulatory T cells in type 1 diabetes B Aghili, AA Amirzargar, A Rajab, A Rabbani, A Sotoudeh, S Assadiasl, ... Iranian Journal of Immunology 12 (4), 240-251, 2015 | 27 | 2015 |
| Regulatory T cell subtypes and TGF-β1 gene expression in chronic allograft dysfunction S Assadiasl, P Ahmadpoor, M Nafar, M Lessan Pezeshki, F Pourrezagholi, ... Iranian Journal of Immunology 11 (3), 139-152, 2014 | 25 | 2014 |
| TLR‐2, TLR‐4 and MyD88 genes expression in renal transplant acute and chronic rejections MH Sharbafi, S Assadiasl, F Pour‐reza‐gholi, S Barzegari, ... International journal of immunogenetics 46 (6), 427-436, 2019 | 19 | 2019 |
| Gene therapy in rheumatoid arthritis: Strategies to select therapeutic genes M Zavvar, S Assadiasl, N Soleimanifar, FD Pakdel, K Abdolmohammadi, ... Journal of cellular physiology 234 (10), 16913-16924, 2019 | 18 | 2019 |
| Interferon regulatory factors: where to stand in transplantation S Assadiasl, A Shahi, S Salehi, S Afzali, A Amirzargar Transplant immunology 51, 76-80, 2018 | 16 | 2018 |
| Tocilizumab in transplantation B Mosharmovahed, Y Fatahi, B Mohebbi, SA Ghorbanian, S Assadiasl European Journal of Clinical Pharmacology 76, 765-773, 2020 | 15 | 2020 |
| COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches M Zavvar, A Yahyapoor, H Baghdadi, S Zargaran, S Assadiasl, ... International Immunopharmacology 107, 108655, 2022 | 12 | 2022 |
| Cytokines in lung transplantation S Assadiasl, MH Nicknam Lung 200 (6), 793-806, 2022 | 11 | 2022 |
| Cytokines in liver transplantation S Assadiasl, N Mooney, MH Nicknam Cytokine 148, 155705, 2021 | 11 | 2021 |
| Toll-Like Receptor 4 in Renal Transplant. S Assadiasl, MJ Mousavi, A Amirzargar experimental and clinical transplantation 16 (3), 245 - 252, 2018 | 10 | 2018 |
| Antiapoptotic molecule survivin in transplantation: helpful or harmful? S Assadiasl, MJ Mousavi, A Amirzargar Journal of Transplantation 2018 (1), 6492034, 2018 | 9 | 2018 |
| MicroRNAs-mediated regulation pathways in rheumatic diseases S Assadiasl, M Rajabinejad, N Soleimanifar, F Makiyan, E Azizi, ... Inflammopharmacology 31 (1), 129-144, 2023 | 8 | 2023 |
| Th17/Treg cell balance in stable liver transplant recipients S Assadiasl, MN Toosi, B Mohebbi, B Ansaripour, N Soleimanifar, M Sadr, ... Transplant Immunology 71, 101540, 2022 | 8 | 2022 |
| Sirtuin 1: a dilemma in transplantation S Assadiasl, N Mooney, B Mohebbi, Y Fatahi, N Soleimanifar Journal of Transplantation 2020 (1), 9012980, 2020 | 8 | 2020 |
| Adoptive Treg cell-based immunotherapy: Frontier therapeutic aspects in rheumatoid arthritis M Zavvar, S Assadiasl, S Zargaran, M Akhtari, B Poopak, R Dinarvand, ... Immunotherapy 12 (12), 933-946, 2020 | 7 | 2020 |
| Natural killer cell subsets and IL-2, IL-15, and IL-18 genes expressions in chronic kidney allograft dysfunction and graft function in kidney allograft recipients S Assadiasl, A Sepanjnia, B Aghili, M Nafar, P Ahmadpoor, ... International journal of organ transplantation medicine 7 (4), 212, 2016 | 7 | 2016 |
| Soluble major histocompatibility complex class I chain-related antigen A level in chronic allograft dysfunction S Assadiasl, P Ahmadpoor, M Nafar, ML Pezeshki, PM Torbati, ... Iranian Journal of Kidney Diseases 9 (2), 146, 2015 | 7 | 2015 |
Narjes SoleimanifarMolecular Immunology research center, Tehran university of medical sciences在 razi.tums.ac.ir 的电子邮件经过验证
